Genetic Assessment of the Patients With Metabolic Syndrome
This trial is active, not recruiting.
|Sponsor||Medical Universtity of Lodz|
|Start date||December 2010|
|End date||August 2011|
|Trial size||300 participants|
|Trial identifier||NCT01268696, RNN/202/10/KE|
Metabolic syndrome is a combination of medical disorders that increase the risk of developing cardiovascular disease and diabetes. The exact mechanisms of the complex pathways of metabolic syndrome are not yet completely known. The pathophysiology is extremely complex and has been only partially elucidated. Most patients are older, obese, sedentary, and have a degree of insulin resistance. Stress can also be a contributing factor. The most important factors are:
weight, genetics, aging, sedentary lifestyle,excess caloric intake. In our study we will assess the role of some polymorphisms in the pathology of metabolic syndrome.
|Observational model||case control|
Patients with metabolic syndrome
Male or female participants from 18 years up to 80 years old.
Inclusion Criteria: - patients with metabolic syndrome according to IDF,AHA and NHLBI 2009 Exclusion Criteria: - diabetes type 1 - cancer - not consent - steroid therapy - alcohol or drug abuse - chronic inflammatory disease - pregnancy or lactation - severe hypothyroidism - immunosuppressive treatment - operation or severe injury during the last month
|Official title||Genetic Assessment of the Patients With Metabolic Syndrome in Polish Population|
|Description||Eligibility criteria to the study: - patients with metabolic syndrome - with written consent|
Call for more information